Overexpression and extended degradation rate of Axl in acquired gefitinib-resistant non-small cell lung cancer cells

被引：0
|
作者：
Kim, Donghwa [1 ]
Bach, Duc-Hiep [1 ]
Hong, Ji-Young [1 ]
Park, Hyen Joo [1 ]
Lee, Sang Kook [1 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-894
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
894
引用
收藏
页数：2
相关论文
共 50 条
  • [21] SerpinB2 enhances invadopodia-like structure protrusions and is down-regulated in acquired gefitinib-resistant non-small cell lung cancer cells
    Bae, Song Yi
    Kim, Donghwa
    Park, Hyen Joo
    Byun, Woong Sub
    Hong, Ji-Young
    Lee, Hye-Jung
    Lee, Sang Kook
    CANCER RESEARCH, 2017, 77
  • [22] Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification
    Yoshida, Takeshi
    Okamoto, Isamu
    Okamoto, Wataru
    Hatashita, Erina
    Yamada, Yuki
    Kuwata, Kiyoko
    Nishio, Kazuto
    Fukuoka, Masahiro
    Janne, Pasi A.
    Nakagawa, Kazuhiko
    CANCER SCIENCE, 2010, 101 (01): : 167 - 172
  • [23] Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
    Tang, Mei-Chuan
    Wu, Mei-Yi
    Hwang, Ming-Hung
    Chang, Ya-Ting
    Huang, Hui-Ju
    Lin, Anya Maan-Yuh
    Yang, James Chih-Hsin
    PLOS ONE, 2015, 10 (03):
  • [24] Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway
    Xie, Ya-Jia
    Gao, Wei-Na
    Wu, Qi-Biao
    Yao, Xiao-Jun
    Jiang, Ze-Bo
    Wang, Yu-Wei
    Wang, Wen-Jun
    Li, Wei
    Hussain, Shahid
    Liu, Liang
    Leung, Elaine Lai-Han
    Fan, Xing-Xing
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [25] Role of adenosine A2a receptors in the growth control of a gefitinib-resistant non-small cell lung cancer cell growth
    Noguchi, Maki
    Kuzumaki, Naoko
    Nagasawa, Atsumi
    Narita, Michiko
    Narita, Minoru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 197P - 197P
  • [26] Combination Effect between Bortezomib and Tumor Necrosis Factor α on Gefitinib-resistant Non-small Cell Lung Cancer Cell Lines
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Ando, Koichi
    Hosaka, Takamichi
    Ishida, Hiroo
    Shirai, Takao
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Hirose, Takashi
    Ohnishi, Tsukasa
    Inoue, Fumiko
    Kanome, Tomoko
    Kadofuku, Tsuyoki
    Saijo, Nagahiro
    Adachii, Mitsuru
    Ohmori, Tohru
    ANTICANCER RESEARCH, 2009, 29 (06) : 2315 - 2322
  • [27] Deoxypodophyllotoxin Inhibits Cell Growth and Induces Apoptosis by Blocking EGFR and MET in Gefitinib-Resistant Non-Small Cell Lung Cancer
    Kim, Han Sol
    Oh, Ha-Na
    Kwak, Ah-Won
    Kim, Eunae
    Lee, Mee-Hyun
    Seo, Ji-Hye
    Cho, Seung-Sik
    Yoon, Goo
    Chae, Jung-Il
    Shim, Jung-Hyun
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2021, 31 (04) : 559 - 569
  • [28] Short-hairpin RNA library: identification of therapeutic partners for gefitinib-resistant non-small cell lung cancer
    Sudo, Makoto
    Mori, Seiichi
    Madan, Vikas
    Yang, Henry
    Leong, Geraldine
    Koeffler, H. Phillip
    ONCOTARGET, 2015, 6 (02) : 814 - 824
  • [29] Antitumor Impact of p14ARF on Gefitinib-Resistant Non-Small Cell Lung Cancers
    Saito, Ken
    Takigawa, Nagio
    Ohtani, Naoko
    Iioka, Hidekazu
    Tomita, Yuki
    Ueda, Ryuzo
    Fukuoka, Junya
    Kuwahara, Kazuhiko
    Ichihara, Eiki
    Kiura, Katsuyuki
    Kondo, Eisaku
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) : 1616 - 1628
  • [30] Overexpression of CTEN is associated with gefitinib resistance in non-small cell lung cancer
    Lu, Xiangdong
    Zhang, Yao
    Pan, Yukai
    Cao, Minmin
    Zhou, Xie
    Zhang, Tingrong
    ONCOLOGY LETTERS, 2021, 21 (01) : 1 - 8
12345